Management of Neurosurgical Patients During the COVID-19 Pandemic
Huaizhang Shi, 
Guang Yang,
Cheng Gao,
Xiaoxiong Wang,
Guan Xin,
Luan Rui,
I. F. Gareev,
O. A. Beylerli,
Sh. Kh. Gantsev,
Shiguang Zhao
Guang Yang,
Cheng Gao,
Xiaoxiong Wang,
Guan Xin,
Luan Rui,
I. F. Gareev,
O. A. Beylerli,
Sh. Kh. Gantsev,
Shiguang Zhao https://doi.org/10.24060/2076-30932020-10-3-177-182
Abstract
The 2019 coronavirus infection (COVID-19) is a dangerous infectious disease proceeding as an acute respiratory viral infection with specific complications, which may include pneumonia leading to acute respiratory distress syndrome or respiratory failure with a high risk of death. The etiological agent of COVID-19 is a new coronavirus, referred to as Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). This new viral form is most likely to have appeared from zoonotic coronaviruses, such as SARS-CoV emerged in 2002. This article sets out to present a strategy for manag‑ ing neurosurgical patients, which was developed taking into account the experience of the Neurosurgery Department of the First Affiliated Hospital of Harbin Medical University in the prevention and control of pneumonia outbreaks caused by the new coronavirus. This strategy can be helpful for neurosurgeons in providing emergency care in the context of the COVID-19 pandemic in the Russian Federation.
About the Authors
Huaizhang Shi
First Affiliated Hospital of Harbin Medical University
China
China
PhD, Professor, Department of Neurosurgery,
Harbin, Heilongjiang Province
Guang Yang
First Affiliated Hospital of Harbin Medical University
China
China
PhD, Professor, Department of Neurosurgery,
Harbin, Heilongjiang Province
Cheng Gao
First Affiliated Hospital of Harbin Medical University
China
China
PhD, Department of Neurosurgery,
Harbin, Heilongjiang Province
Xiaoxiong Wang
First Affiliated Hospital of Harbin Medical University
China
China
PhD, Department of Neurosurgery,
Harbin, Heilongjiang Province
Guan Xin
First Affiliated Hospital of Harbin Medical University
China
China
Department of Infectious Disease,
Harbin, Heilongjiang Province
Luan Rui
First Affiliated Hospital of Harbin Medical University
China
China
Department of Medical Assistance,
Harbin, Heilongjiang Province
I. F. Gareev
Bashkir State Medical University
Russian Federation
Russian Federation
Cand. Sci. (Med.), Department of Oncology with courses of oncology and pathological anatomy for Advanced Professional Education,
Ufa
O. A. Beylerli
Bashkir State Medical University
Russian Federation
Russian Federation
Department of Oncology with courses of oncology and pathological anatomy for Advanced Professional Education,
Ufa
Sh. Kh. Gantsev
Bashkir State Medical University
Russian Federation
Russian Federation
Dr. Sci. (Med.), Professor, Department of Oncology with courses of oncology and pathological anatomy for Advanced Professional Education,
Ufa
Shiguang Zhao
First Affiliated Hospital of Harbin Medical University
China
China
PhD, Professor, Department of Neurosurgery,
Harbin, Heilongjiang Province
References
1. Kannan S., Shaik Syed Ali P., Sheeza A., Hemalatha K. COVID-19 (Novel Coronavirus 2019) — recent trends. Eur Rev Med Pharmacol Sci. 2020;24(4):2006–11. DOI: 10.26355/eurrev_202002_20378
2. Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281–6. DOI: 10.1007/s12098-020-03263-6
3. Sifuentes-Rodríguez E., Palacios-Reyes D. COVID-19: The outbreak caused by a new coronavirus. Bol Med Hosp Infant Mex. 2020;77(2):47–53. DOI: 10.24875/BMHIM.20000039
4. Trojánek M., Grebenyuk V., Herrmannová K., Nečas T., Gregorová J., Kucbel M., et al. A novel coronavirus (SARS-CoV-2) and COVID-19. Cas Lek Cesk. 2020;159(2):55–66.
5. National health commission of the People’s Republic of China [Internet]. Diagnosis and treatment scheme of Covid-19 (Sixth Trial Version) [cited 2020 Sept 27]. Available from: http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml
6. Xuan Wang, Xiaobing Jiang, Haijun Wang, et al. Emergency procedures and strategies for prevention and control of Covid-19 in neurosurgery [Internet]. Chinese Medical Association [cited 2020 Sept 27]. Available from: http://cns.cma.org.cn/art/2020/2/12/art_2196_32579.html?from=singlemessage&isappinstalled=0
7. Neurointerventional Committee of Chinese Medical Doctor Association [Internet]. Expert recommendation for prevention and control of Covid-19 in neurointervention [cited 2020 Sept 27]. Available from: https://mp.weixin.qq.com/s/DUkFKiw7I59tzbVakHP7uQ
8. Barrow D.L., Bendok B.R. Introduction: What is neurosurgery? Oper Neurosurg (Hagerstown). 2019;17(Suppl 2):S1–S2. DOI: 10.1093/ons/opz071
9. Ahn D.G., Shin H.J., Kim M.H., Lee S., Kim H.S., Myoung J., et al. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19). J Microbiol Biotechnol. 2020;30(3):313–24. DOI: 10.4014/jmb.2003.03011
10. Li H., Liu S.M., Yu X.H., Tang S.L., Tang C.K. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020;55(5):105951. DOI: 10.1016/j.ijantimicag.2020.105951
Review
For citations:
Shi H., Yang G., Gao Ch., Wang X., Xin G., Rui L., Gareev I.F., Beylerli O.A., Gantsev Sh.Kh., Zhao Sh. Management of Neurosurgical Patients During the COVID-19 Pandemic. Creative surgery and oncology. 2020;10(3):177-182. (In Russ.) https://doi.org/10.24060/2076-30932020-10-3-177-182
Views:
1011
Email this article 